Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessRIG-I signaling pathway

PUM2 MAVS PUM1

1.21e-0530313GO:0039529
GeneOntologyBiologicalProcessstress granule assembly

PUM2 UBAP2L PRKAA2

2.12e-0536313GO:0034063
GeneOntologyBiologicalProcesspositive regulation of RIG-I signaling pathway

PUM2 PUM1

1.19e-0411312GO:1900246
GeneOntologyBiologicalProcesspositive regulation of miRNA-mediated gene silencing

PUM2 PUM1

1.43e-0412312GO:2000637
GeneOntologyBiologicalProcessregulation of stress granule assembly

UBAP2L PRKAA2

1.43e-0412312GO:0062028
GeneOntologyBiologicalProcesspositive regulation of post-transcriptional gene silencing by RNA

PUM2 PUM1

1.69e-0413312GO:1900370
GeneOntologyBiologicalProcesspositive regulation of post-transcriptional gene silencing

PUM2 PUM1

1.69e-0413312GO:0060148
GeneOntologyBiologicalProcesspositive regulation of pattern recognition receptor signaling pathway

PUM2 MAVS PUM1

2.25e-0479313GO:0062208
GeneOntologyBiologicalProcessmagnesium ion homeostasis

TMEM94 PTHLH

2.93e-0417312GO:0010960
GeneOntologyBiologicalProcess3'-UTR-mediated mRNA destabilization

PUM2 PUM1

3.68e-0419312GO:0061158
GeneOntologyCellularComponentcytoplasmic stress granule

PUM2 PUM1 UBAP2L PRKAA2

1.19e-0596314GO:0010494
GeneOntologyCellularComponentcytoplasmic ribonucleoprotein granule

PUM2 PUM1 UBAP2L PRKAA2

6.42e-04269314GO:0036464
GeneOntologyCellularComponentribonucleoprotein granule

PUM2 PUM1 UBAP2L PRKAA2

8.17e-04287314GO:0035770
DomainPumilio_RNA-bd

PUM2 PUM1

2.67e-062312IPR033712
DomainPUM-HD

PUM2 PUM1

7.99e-063312IPR033133
DomainPUF

PUM2 PUM1

7.99e-063312PF00806
DomainPUM_HD

PUM2 PUM1

7.99e-063312PS50303
DomainPumilio_RNA-bd_rpt

PUM2 PUM1

1.60e-054312IPR001313
DomainPUM

PUM2 PUM1

1.60e-054312PS50302
DomainPumilio

PUM2 PUM1

1.60e-054312SM00025
DomainCUB

CSMD1 CSMD2 CSMD3

7.24e-0549313PF00431
DomainCUB

CSMD1 CSMD2 CSMD3

7.70e-0550313SM00042
DomainSushi

CSMD1 CSMD2 CSMD3

8.66e-0552313PF00084
Domain-

CSMD1 CSMD2 CSMD3

8.66e-05523132.60.120.290
DomainCUB

CSMD1 CSMD2 CSMD3

9.17e-0553313PS01180
DomainCCP

CSMD1 CSMD2 CSMD3

9.70e-0554313SM00032
DomainSUSHI

CSMD1 CSMD2 CSMD3

1.08e-0456313PS50923
DomainSushi_SCR_CCP_dom

CSMD1 CSMD2 CSMD3

1.14e-0457313IPR000436
DomainCUB_dom

CSMD1 CSMD2 CSMD3

1.14e-0457313IPR000859
DomainPH_dom-like

PRKD2 TNS4 ARHGEF10 ARHGAP21

5.16e-03426314IPR011993
DomainCH

NAV2 MICAL3

5.20e-0365312SM00033
DomainCH

NAV2 MICAL3

6.00e-0370312PF00307
Domain-

NAV2 MICAL3

6.17e-03713121.10.418.10
DomainCH

NAV2 MICAL3

6.51e-0373312PS50021
DomainCH-domain

NAV2 MICAL3

6.86e-0375312IPR001715
Pubmed

Identification of two new members of the CSMD gene family.

CSMD1 CSMD2 CSMD3

6.41e-10331312906867
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PUM2 MICAL3 PUM1 CSMD3 UBAP2L TMEM94 ARHGAP21

5.89e-0840731712693553
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

NAV2 FOXO4 WWC2 PUM1 ARHGEF10 AMOT ARHGAP21 PRKAA2

6.50e-0786131836931259
Pubmed

A genetic association study of CSMD1 and CSMD2 with cognitive function.

CSMD1 CSMD2

7.69e-07231227890662
Pubmed

A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.

PUM2 PUM1

7.69e-07231231078383
Pubmed

Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.

PUM2 PUM1

7.69e-07231232753408
Pubmed

The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.

CSMD1 CSMD2

7.69e-07231221439553
Pubmed

Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

CSMD1 CSMD2

7.69e-07231224408017
Pubmed

Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.

PUM2 PUM1

7.69e-07231212459267
Pubmed

PUMILIO proteins promote colorectal cancer growth via suppressing p21.

PUM2 PUM1

7.69e-07231235338151
Pubmed

Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.

PUM2 PUM1

7.69e-07231229165587
Pubmed

Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.

PUM2 PUM1

7.69e-07231232437472
Pubmed

PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.

PUM2 PUM1

7.69e-07231235507203
Pubmed

Bespoke RNA recognition by Pumilios.

PUM2 PUM1

7.69e-07231226517885
Pubmed

Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.

PUM2 PUM1

7.69e-07231212667987
Pubmed

Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.

PUM2 PUM1

7.69e-07231212771951
Pubmed

Alternate modes of cognate RNA recognition by human PUMILIO proteins.

PUM2 PUM1

7.69e-07231221397187
Pubmed

Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.

PUM2 PUM1

7.69e-07231218776931
Pubmed

Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.

PUM2 PUM1

7.69e-07231232316190
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

AKAP6 NAV2 PUM2 ARHGEF10 AMOT

1.61e-0622531512168954
Pubmed

Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs.

PUM2 PUM1

2.31e-06331230333515
Pubmed

Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome.

PUM2 PUM1

2.31e-06331233397688
Pubmed

NORAD: Defender of the Genome.

PUM2 PUM1

2.31e-06331227157388
Pubmed

COP9 signalosome component CSN-5 stabilizes PUF proteins FBF-1 and FBF-2 in Caenorhabditis elegans germline stem and progenitor cells.

PUM2 PUM1

2.31e-06331238427913
Pubmed

A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection.

PUM2 PUM1

2.31e-06331225340845
Pubmed

PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.

PUM2 PUM1

2.31e-06331228232582
Pubmed

Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.

PUM2 PUM1

2.31e-06331226724866
Pubmed

Pumilio facilitates miRNA regulation of the E2F3 oncogene.

PUM2 PUM1

2.31e-06331222345517
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

PUM2 PUM1 UBAP2L AMOT ARHGAP21

4.20e-0627431534244482
Pubmed

Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.

PUM2 PUM1

4.61e-06431230811992
Pubmed

Target RNA motif and target mRNAs of the Quaking STAR protein.

PUM2 PUM1

4.61e-06431216041388
Pubmed

PUM1 and PUM2 exhibit different modes of regulation for SIAH1 that involve cooperativity with NANOS paralogues.

PUM2 PUM1

7.68e-06531230269240
Pubmed

An Important Role of Pumilio 1 in Regulating the Development of the Mammalian Female Germline.

PUM2 PUM1

7.68e-06531227170441
Pubmed

N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1.

MAVS NFE2L1

7.68e-06531230135079
Pubmed

The RNA-binding protein Musashi-1 is produced in the developing and adult mouse eye.

PUM2 PUM1

1.15e-05631217768378
Pubmed

Pumilio proteins utilize distinct regulatory mechanisms to achieve complementary functions required for pluripotency and embryogenesis.

PUM2 PUM1

1.15e-05631232198202
Pubmed

Post-transcriptional gene expression control by NANOS is up-regulated and functionally important in pRb-deficient cells.

PUM2 PUM1

1.61e-05731225100735
Pubmed

Staufen 1 is expressed by neural precursor cells in the developing murine cortex but is dispensable for NPC self-renewal and neuronal differentiation in vitro.

PUM2 PUM1

1.61e-05731234678304
Pubmed

Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.

CSMD1 CSMD2 CSMD3

2.46e-056331311572484
Pubmed

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.

PUM2 WWC2 OAZ1 PUM1 ARHGEF10 UBAP2L NFE2L1

2.61e-05102131726760575
Pubmed

Sertoli cell PUMILIO proteins modulate mouse testis size through translational control of cell cycle regulators.

PUM2 PUM1

2.76e-05931235678316
Pubmed

The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA function.

PUM2 PUM1

3.44e-051031223125361
Pubmed

Cellular functions of long noncoding RNAs.

PUM2 PUM1

3.44e-051031231048766
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

AKAP6 WWC2 PUM1 UBAP2L NFE2L1 AMOT ARHGAP21

3.83e-05108431711544199
Pubmed

Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.

CSMD2 PUM1

4.21e-051131216429158
Pubmed

Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins.

PUM2 PUM1

5.96e-051331212511597
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

AKAP6 FAM114A1 NFE2L1 AMOT ARHGAP21

7.30e-0549731523414517
Pubmed

OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.

WWC2 UBAP2L AMOT

7.39e-059131330472188
Pubmed

The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression.

PUM1 UBAP2L AMOT

8.93e-059731337151849
Pubmed

Essential requirement of mammalian Pumilio family in embryonic development.

PUM2 PUM1

9.16e-051631230256721
Pubmed

Functional analysis of candidate genes from genome-wide association studies of hearing.

CSMD1 PTHLH

1.04e-041731231927188
Pubmed

PTPN14 is required for the density-dependent control of YAP1.

WWC2 AMOT

1.60e-042131222948661
Pubmed

Dead end1 is an essential partner of NANOS2 for selective binding of target RNAs in male germ cell development.

PUM2 PUM1

1.76e-042231226589352
Pubmed

Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling.

MAVS PUM1 AMOT PRKAA2

2.09e-0433231429053956
Pubmed

Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies.

CSMD2 ITGAE

2.86e-042831218839057
Pubmed

Post-transcriptional regulation of mouse neurogenesis by Pumilio proteins.

PUM2 PUM1

3.08e-042931228794184
Pubmed

Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.

NAV2 MICAL3 ARHGAP21

3.43e-0415331310718198
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

NAV2 PRKD2 MICAL3 PUM1 TMEM94 ARHGAP21

3.78e-04110531635748872
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

PUM2 MAVS PUM1 ARHGEF10 TMEM94

4.42e-0473331534672954
Pubmed

Genome-wide association study of selenium concentrations.

CSMD1 ARHGEF10

4.49e-043531225343990
Pubmed

Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

PDZD7 ARHGAP21

4.75e-043631226053890
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

MICAL3 ARHGEF10 TMEM94 ARHGAP21

5.14e-0442131436976175
Pubmed

EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.

UBAP2L AMOT

7.11e-044431227505670
Pubmed

Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.

CSMD1 UBAP2L

7.11e-044431220200978
InteractionSFN interactions

NAV2 FOXO4 WWC2 TNS4 PUM1 ARHGEF10 AMOT ARHGAP21 PRKAA2

6.45e-07692319int:SFN
CytobandEnsembl 112 genes in cytogenetic band chr1p35

CSMD2 PUM1

3.88e-03137312chr1p35
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CSMD1 CSMD2 CSMD3

3.80e-05572131179
CoexpressionGSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN

CCNJL NAV2 FAM114A1 MAVS PRKAA2

9.85e-07154315M8912
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

FOXO4 PUM1 UBAP2L INO80D

5.20e-0616631432d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCellASK428-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

MUC16 FAM114A1 CSMD1 ARHGEF10

6.41e-06175314e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

AKAP6 FOXO4 CSMD3 INO80D

6.70e-06177314e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FOXO4 MICAL3 CSMD1 NFE2L1

7.01e-06179314d2db9e70b780643f1e004c41a70464d0abe26088
ToppCellCOVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class

NAV2 MUC16 PRR36 PRKAA2

8.51e-06188314a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCellNS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MUC16 FAM114A1 SYTL5 PRKAA2

9.82e-06195314b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCellParenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

MUC16 TNS4 CSMD1 CSMD3

1.04e-05198314686eda427b075e788de38149eae82faf19bd5704
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC16 TNS4 CSMD1 CSMD3

1.04e-05198314a54ae5275a510b49d7629f0908817a0c5f05020e
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC16 TNS4 CSMD1 CSMD3

1.04e-0519831434997e3896d0893fbe51bfb0d4660ccaca1c975e
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NAV2 MUC16 SYTL5 PRKAA2

1.06e-051993147223f853335492ca617dbec3e4b6872a8a463a45
ToppCellTracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 FAM114A1 TNS4 PRKAA2

1.09e-05200314682960e28542a3d6c119047cd0131941932cfdea
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

1.35e-041443137de962346ba9653d90dd13bb7d977fe44d200bba
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

CSMD1 CSMD2 CSMD3

1.41e-04146313c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

1.62e-041533139c6fce56300ba5053efda59a438d63a808c497c0
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FAM114A1 CSMD3 PTHLH

1.68e-041553133b8def9e8f66511736ea37f259511f7c8b7743af
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

CSMD1 CSMD2 CSMD3

1.81e-041593135335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

1.88e-041613133b5d7a3dab479c6959a428f3954dedd989900276
ToppCellBasal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

TNS4 AMOT PRKAA2

1.95e-04163313679e25e5548d157d49a73057a3b5617dccda260f
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MICAL3 INO80D PRKAA2

1.98e-04164313d6f71d804bb65301c02ea4e6673e20688b5fcd5b
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

2.02e-04165313c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCellfacs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNS4 CSMD3 TMEM94

2.05e-04166313b21e45bd43f26149b9cd6e45c19241c82d54fb2f
ToppCellfacs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNS4 CSMD3 TMEM94

2.05e-0416631313027ae342994db4540e64eb910df1f42b160931
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

2.09e-041673131c1b4722c6c0eff85a9b32ca7b4e281caebf63b0
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CSMD1 CSMD2 CSMD3

2.09e-041673133edb0570e583bb527165bcd8a4c25a042054043b
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNS4 CSMD1 PTHLH

2.20e-041703132d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNS4 CSMD1 PTHLH

2.20e-041703130cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

2.24e-041713135efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 SYTL5 PTHLH

2.28e-041723137e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 SYTL5 PRKAA2

2.32e-04173313176b956e71d98e8275d698b39437fc326e5fe449
ToppCellASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

MUC16 CSMD1 ARHGEF10

2.36e-04174313b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCellNasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

TNS4 CSMD3 PTHLH

2.44e-04176313fc5787946f5a10056d326d070620575ae4081836
ToppCellNasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

TNS4 CSMD3 PTHLH

2.44e-041763135daaba0853afe7d20d4635169ccd4f96e735b938
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV2 MICAL3 CSMD2

2.52e-04178313a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 ARHGAP21 PRKAA2

2.56e-041793136e965e424eebef50f0202cff75f458be395cfca1
ToppCellRV|World / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

2.65e-04181313bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AKAP6 CSMD1 PTHLH

2.65e-04181313098dbb3e0ff531c9720a233123250c1e39a97d4c
ToppCellCOVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 MICAL3 PRKAA2

2.69e-04182313287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AKAP6 CSMD1 CSMD2

2.87e-04186313a95744b8649096bd7cfc3591a02841fa411085b3
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AKAP6 CSMD1 CSMD2

2.87e-041863134780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MUC16 CSMD1 CSMD3

2.87e-0418631323b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellRV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

2.92e-0418731378cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCellfacs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP6 SPDYA PRKAA2

2.92e-04187313f1e9877d859369b862d4a559ec9ab9be74a67a96
ToppCellfacs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP6 SPDYA PRKAA2

2.92e-041873133ffbd50b49059dcd3e23c5ac01901e4352142446
ToppCellLV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

2.96e-041883130758b474457efa36488e0195f7357100f4b6a090
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

3.01e-041893135e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV2 SPDYA MICAL3

3.01e-041893135d902a4660a27548764bf04c6de152b565da835c
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV2 SPDYA MICAL3

3.01e-041893138c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellRV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

3.01e-041893139c1debd65c13d63fd4f3158917d621b44b714c26
ToppCellCOVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations)

MUC16 TNS4 PRKAA2

3.05e-0419031351ca9ef4df3220487152fcf684147730637c7cc1
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

3.05e-04190313fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AKAP6 CSMD1 CSMD2

3.05e-0419031373d94fbae92029745989a8712eed8b99fd84c193
ToppCellLA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

3.10e-041913135d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

3.15e-04192313ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AKAP6 NAV2 PRKAA2

3.20e-04193313173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 FAM114A1 PRKAA2

3.20e-04193313605fc2a25ed6846fb283b2918cfed98df6039d6b
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 MICAL3 PRKAA2

3.20e-04193313dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

AKAP6 MICAL3 PRKAA2

3.25e-04194313c3535f7cc0076653c72db582047cff053c322397
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MUC16 CSMD1 CSMD2

3.30e-0419531319853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 MICAL3 PRKAA2

3.30e-0419531375fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FAM114A1 AMOT PRKAA2

3.30e-041953133f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MUC16 CSMD1 CSMD2

3.30e-04195313d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCellSecretory|World / shred by cell class for bronchial biopsy

MUC16 FAM114A1 SYTL5

3.30e-0419531352f8281fe0df67cec3faa780a23ed6343ed5a6ba
ToppCell(05)_Secretory|World / shred by cell type by condition

CCNJL MUC16 PRKAA2

3.34e-041963138032c25b51ef96aeba28cc52686a2bd45213453d
ToppCellCOVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type

AKAP6 NFE2L1 PRKAA2

3.40e-0419731344e49943d62bfe622b40ad0460093d31540544df
ToppCellNS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FAM114A1 TNS4 PRKAA2

3.40e-04197313a72047b7428c0d4aaf016c1ac23dc30919260fd8
ToppCellPSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FAM114A1 SYTL5 PRKAA2

3.45e-04198313e4cbe4032dba0da3fd46817ea9ad86ba9217f747
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.45e-04198313b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellmoderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MUC16 FAM114A1 PRKAA2

3.45e-041983137d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.45e-0419831385f424cd9bb3117c9e322031024aabb87696ce47
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 TNS4 PRKAA2

3.45e-04198313de5987588b9fa9ee8c595ba06d7d844ead0e3c74
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.45e-041983131282db321e27499d310339d6383974614e295a20
ToppCellBronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 TNS4 PRKAA2

3.45e-041983131fe60443c11d34b6d2671af8f06e0dedc8d1558b
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.50e-04199313d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.50e-041993131c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.50e-04199313a270630626df614f8605abddb7dee7c4d74f6149
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CSMD1 CSMD2 CSMD3

3.50e-0419931319a97e27a4758e794ce7246d295e112b47931a48
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CSMD1 CSMD2 CSMD3

3.50e-04199313333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 SYTL5 PRKAA2

3.50e-04199313e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CSMD1 CSMD2 CSMD3

3.50e-04199313e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCellBiopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type

MUC16 TNS4 PRKAA2

3.50e-04199313afd0df242a93f176438309668a9487be1250d9ca
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.55e-04200313ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellParenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

MUC16 SYTL5 PRKAA2

3.55e-0420031385f946dd3831acf3488c87efba96689cc2667c3a
ToppCellMacroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

CSMD1 CSMD2 CSMD3

3.55e-04200313310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCellBronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 FAM114A1 PRKAA2

3.55e-04200313ed093626a9cac7531a2bf02f6e345c5e84b8c060
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC16 SYTL5 PRKAA2

3.55e-042003138a44a4f7ea9358f2194a490e79601c98ff7fdcb0
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

AKAP6 CSMD1 CSMD2

3.55e-042003139169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCellMacroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic

CSMD1 CSMD2 CSMD3

3.55e-04200313c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.55e-042003138683445ad5b70748c4a1f12eb77d47623085147e
ToppCellMacroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic

CSMD1 CSMD2 CSMD3

3.55e-042003134fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC16 SYTL5 PRKAA2

3.55e-0420031330d428510c68da96c7c8cfd472f449ebb9631132
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

NAV2 WWC2 SYTL5

3.55e-042003132dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellMacroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic

CSMD1 CSMD2 CSMD3

3.55e-04200313f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCellMacroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic

CSMD1 CSMD2 CSMD3

3.55e-04200313cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCellMacroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

CSMD1 CSMD2 CSMD3

3.55e-04200313961858738ce35db8760c8c2e136f8369bc444ccf
ToppCellBronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

MUC16 FAM114A1 SYTL5

3.55e-04200313292c63693eb7f435335a8cfba07aa35b72139393
ToppCellBronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MUC16 FAM114A1 PRKAA2

3.55e-0420031385c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCellHippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Nnat-Inhibitory_Gad1Gad2_Htr3a.Nnat_(Interneuron,__(candidate_CGE-derived_1))-|Hippocampus / BrainAtlas - Mouse McCarroll V32

TNS4 ITGAE

6.91e-045631245241df25dfb0374e387391f7f6ea9d8d2564356
ToppCellHippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Nnat-Inhibitory_Gad1Gad2_Htr3a.Nnat_(Interneuron,__(candidate_CGE-derived_1))|Hippocampus / BrainAtlas - Mouse McCarroll V32

TNS4 ITGAE

6.91e-04563128e988e3b2c034f0418d90f2be35c42bd181b044f
ToppCellHippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Nnat|Hippocampus / BrainAtlas - Mouse McCarroll V32

TNS4 ITGAE

6.91e-04563127fb4d1ee114f5ee481775bb5b6fee424147642db
Diseasecoronary aneurysm

NAV2 CSMD1 CSMD2

6.07e-0635303EFO_1000881
Diseaseattention deficit hyperactivity disorder

AKAP6 NAV2 CSMD2 ITGAE PTHLH

2.69e-05354305EFO_0003888
Diseaseserum gamma-glutamyl transferase measurement

NAV2 WWC2 MICAL3 CSMD1 CSMD3 ARHGAP21

2.73e-04914306EFO_0004532
Diseaseresponse to TNF antagonist, joint damage measurement

NAV2 CSMD3

2.95e-0425302EFO_0004653, EFO_0005413
Diseaseuridine measurement

PRKD2 CSMD1

4.86e-0432302EFO_0010546
Diseaseblood molybdenum measurement

AKAP6 ARHGEF10

6.87e-0438302EFO_0007582
DiseaseGastric Adenocarcinoma

PRKD2 PRKAA2

9.63e-0445302C0278701
Diseaseheart rate variability measurement, response to antipsychotic drug

NAV2 CSMD1

1.01e-0346302EFO_0008003, GO_0097332
DiseaseTourette syndrome

MUC16 CSMD3

1.19e-0350302EFO_0004895
Diseaseobesity (implicated_via_orthology)

PUM2 PUM1 PRKAA2

1.34e-03215303DOID:9970 (implicated_via_orthology)
Diseasealcohol dependence measurement

FAM114A1 ARHGAP21

1.44e-0355302EFO_0007835
Diseaseschizophrenia (implicated_via_orthology)

CSMD1 CSMD3

2.18e-0368302DOID:5419 (implicated_via_orthology)
Diseasejoint damage measurement

CCNJL CSMD1

2.18e-0368302EFO_0005413
Diseaseanorexia nervosa

AKAP6 SYTL5

2.31e-0370302MONDO_0005351
Diseasecleft lip

AKAP6 MUC16 CSMD1

2.96e-03284303EFO_0003959
Diseaseeye color

MUC16 CSMD1

3.79e-0390302EFO_0003949
Diseaseankylosing spondylitis

AKAP6 CSMD1

3.87e-0391302EFO_0003898
DiseaseS-7-hydroxywarfarin measurement

CSMD1 CSMD2

5.60e-03110302EFO_0803329
DiseaseDrug Use Disorders

CSMD1 CSMD3

6.10e-03115302C0013222
DiseaseDrug Dependence

CSMD1 CSMD3

6.10e-03115302C1510472
DiseaseDrug habituation

CSMD1 CSMD3

6.10e-03115302C0013170
DiseaseSubstance Dependence

CSMD1 CSMD3

6.10e-03115302C0038580
DiseaseSubstance Use Disorders

CSMD1 CSMD3

6.10e-03115302C0038586
DiseaseSubstance-Related Disorders

CSMD1 CSMD3

6.10e-03115302C0236969
DiseaseDrug abuse

CSMD1 CSMD3

6.10e-03115302C0013146
DiseaseOrganic Mental Disorders, Substance-Induced

CSMD1 CSMD3

6.10e-03115302C0029231
DiseasePrescription Drug Abuse

CSMD1 CSMD3

6.10e-03115302C4316881
DiseaseSubstance abuse problem

CSMD1 CSMD3

6.20e-03116302C0740858
Diseaseatrial fibrillation

AKAP6 NAV2 ARHGAP21

6.22e-03371303EFO_0000275
Diseaseresponse to vaccine

MICAL3 CSMD1

6.84e-03122302EFO_0004645
Diseasewhite matter microstructure measurement

NAV2 ARHGAP21 PTHLH

7.14e-03390303EFO_0005674
DiseaseFEV/FEC ratio

AKAP6 NAV2 WWC2 MICAL3 CSMD1

7.41e-031228305EFO_0004713
Diseasealcohol consumption measurement

AKAP6 MICAL3 CSMD1 CSMD3 INO80D

7.77e-031242305EFO_0007878

Protein segments in the cluster

PeptideGeneStartEntry
ISNAGSGLLSHSSTL

AMOT

791

Q4VCS5
LSSSSGSLSLSHGSS

ARHGEF10

1281

O15013
LSSLSGSHSGETLPL

CSMD1

1691

Q96PZ7
SSLSGSHTGESLPLA

CSMD2

1686

Q7Z408
SLLSSLSGSHSGESL

CSMD3

1826

Q7Z407
TAESHSLSGSLTGSL

PRKAA2

506

P54646
SLSGSLTGSLTGSTL

PRKAA2

511

P54646
SGSLLSGSTGSSLHT

CCNJL

366

Q8IV13
DSGLSLDSSHSPSSL

NFE2L1

476

Q14494
LSSHGSSSSLHLGGL

PUM2

641

Q8TB72
STSLSEALSSGHSGV

MUC16

2066

Q8WXI7
LDTSTTLSQGGTHST

MUC16

5286

Q8WXI7
ELSSSSGLGLHGSSS

MICAL3

1421

Q7RTP6
ELGSTHTAGATSSLT

MAVS

201

Q7Z434
HSLSSELTGTCSLLG

ITGAE

116

P38570
NLTSSHSLLSRSGLS

FOXO4

311

P98177
DLSSGSLSSLSSRGH

PDZD7

16

Q9H5P4
SLSSLSSRGHLGSDS

PDZD7

21

Q9H5P4
LSSTSLASGHSVRLG

PRKD2

196

Q9BZL6
LLSLHSRGGSSSESS

OAZ1

36

P54368
PSLSSHGSSSSLNLG

PUM1

761

Q14671
LLGADGHLLSTSLST

INO80D

906

Q53TQ3
SLLSSASATVGHGLT

FAM114A1

136

Q8IWE2
THRLASGLSTTSLNS

SYTL5

376

Q8TDW5
GLSSSSSLSSHTAGV

SPDYA

241

Q5MJ70
SSTLSGPDLAGHSSS

PRR36

1111

Q9H6K5
LVHGSSLSLVSSTSS

NAV2

1666

Q8IVL1
LLSHSSSIESLSPGG

AKAP6

1561

Q13023
SSLGSLASSRGSLNT

WWC2

441

Q6AWC2
LTTTNQHSSSLGGLS

UBAP2L

666

Q14157
TLSHSSSLLHSLGSV

TMEM94

396

Q12767
ANSSSSLHSLGSVSL

TNS4

311

Q8IZW8
GLEGDHLSDTSTTSL

PTHLH

156

P12272
SSHLEETGSDSGTLL

ARHGAP21

1536

Q5T5U3